Sequentially Released Liposomes Enhance Anti-Liver Cancer Efficacy of Tetrandrine and Celastrol-Loaded Coix Seed Oil

References

• Hassan S, Kamel A, Hashem H, et al. Drug delivery systems between metal, liposome, and polymer-based nanomedicine: a review. Eur Chem Bull. 2020;9(3). doi:10.17628/ecb.2020.9.91-102
   Google Scholar
• Bharadwaj A, Gupta M, Shakya A. A critical review on nanotechnology: a technique in cancer detection and prophylaxis. Nano Life. 2023;13(03). doi:10.1142/S1793984423300042
   Web of Science ®Google Scholar
• Mpekris F, Papageorgis P, Polydorou C, et al. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo-and nanotherapy. J Control Release. 2017;261:105–112. doi:10.1016/j.jconrel.2017.06.022
   PubMed Web of Science ®Google Scholar
• Bree C, Krooshoop J, Rietbroek R, et al. Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor. Cancer Res. 1996;56(3):563. doi:10.1097/00002820-199602000-00010
   PubMed Web of Science ®Google Scholar
• Glantz M, Lafollette S, Jaeckle K, et al. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol. 1999;17(10):3110–3116. doi:10.1161/01.CIR.62.3.485
   PubMed Web of Science ®Google Scholar
• Silverman J, Deitcher S. Marqibo (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemother Pharmacol. 2013;71(3):555–564. doi:10.1007/s00280-012-2042-4
   PubMed Web of Science ®Google Scholar
• Fei X. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci. 2010;15(1):166–179. doi:10.2741/3613
   Google Scholar
• Francesco E, Lappano R, Santolla MF, et al. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs). Breast Cancer Res. 2013;15(4):R64. doi:10.1186/bcr3458
   PubMed Web of Science ®Google Scholar
• Jing J, Parekh H, Wei M, et al. Advances in analytical technologies to evaluate the quality of traditional Chinese medicines. Trends Anal Chem. 2013;44:39–45. doi:10.1016/j.trac.2012.11.006
   Web of Science ®Google Scholar
• Wong C, Seow W, O’Callaghan J, et al. Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumor necrosis factor and platelet activating factor. Agents Actions. 1992;36(1–2):112–118. doi:10.1007/BF01991238
   PubMedGoogle Scholar
• Liu C, Gong K, Mao X, Li W. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int J Cancer. 2011;129(6):1519–1531. doi:10.1002/ijc.25817
   PubMed Web of Science ®Google Scholar
• Gao L, Feng Q, Zhang X, et al. Tetrandrine suppresses articular inflammatory response by inhibiting pro-inflammatory factors via NF-κB inactivation. J Orthop Res. 2016;34(9):1557–1568. doi:10.1002/jor.23155
   PubMed Web of Science ®Google Scholar
• Wang X, Yang Y, Yang D, et al. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1. J Vascular Surg. 2016;64(5):1468–1477. doi:10.1016/j.jvs.2015.09.016
   PubMed Web of Science ®Google Scholar
• Liu B, Wang T, Qian X, et al. Anticancer effect of tetrandrine on primary cancer cells isolated from ascites and pleural fluids. Cancer Lett. 2008;268:166–175. doi:10.1016/j.canlet.2008.03.059
   PubMed Web of Science ®Google Scholar
• Bellik Y, Boukraâ L, Alzahrani H, et al. Molecular mechanism underlying anti-inflammatory and anti-allergic activities of phytochemicals: an update. Molecules. 2013;18:322–353. doi:10.3390/molecules18010322
   Web of Science ®Google Scholar
• Zhao H, Lou F, Li H, et al. Antinociceptive effect of tetrandrine on LPS-induced hyperalgesia via the inhibition of IKKb phosphorylation and the COX- 2/PGE2 pathway in mice. PLoS One. 2014;9:e94586. doi:10.1371/journal.pone.0094586
   PubMed Web of Science ®Google Scholar
• Lin Y, Chang C, Wu C, et al. Anti-nociceptive, anti-inflammatory and toxicological evaluation of Fang-Ji-Huang-Qi-Tang in rodents. BMC Complement Altern Med. 2015;15:10. doi:10.1186/s12906-015-0527-5
   PubMed Web of Science ®Google Scholar
• Li X, Jin Q, Wu Y, et al. Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling. Int Immunopharmacol. 2016;36:263–270. doi:10.1016/j.intimp.2016.04.039
   PubMed Web of Science ®Google Scholar
• Gao S, Cui Y, Yu C, et al. Tetrandrine exerts antidepressant-like effects in animal models: role of brain-derived neurotrophic factor. Behav. Brain Res. 2013;238:79–85. doi:10.1016/j.bbr.2012.10.015
   PubMed Web of Science ®Google Scholar
• Yuan X, Tong B, Dou Y, et al. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon. Biochem Pharmacol. 2016;101:87–99. doi:10.1016/j.bcp.2015.11.025
   PubMed Web of Science ®Google Scholar
• Li X, Wu Z, He B, et al. Tetrandrine alleviates symptoms of rheumatoid arthritis in rats by regulating the expression of cyclooxygenase-2 and inflammatory factors. Exp Ther Med. 2018;16:2670–2676. doi:10.3892/etm.2018.6498
   PubMed Web of Science ®Google Scholar
• Jang BC. Tetrandrine has anti-adipogenic effect on 3T3-L1 preadipocytes through the reduced expression and/or phosphorylation levels of C/EBP-a, PPAR-c, FAS, perilipin A, and STAT-3. Biochem Biophys Res Commun. 2017;494:422–423. doi:10.1016/j.bbrc.2016.05.150
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Kolokoltsov A, Chen C, et al. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science. 2015;347:995–998. doi:10.1126/science.1258758
   PubMed Web of Science ®Google Scholar
• Capuzzi S, Sun W, Muratov E, et al. Computer-aided discovery and characterization of novel Ebola virus inhibitors. J Med Chem. 2018;61:3582–3594. doi:10.1021/acs.jmedchem.8b00035
   PubMed Web of Science ®Google Scholar
• Lv Y, Wu Z, Chen L, et al. Neuroprotective effects of tetrandrine against vascular dementia. Neural Regen Res. 2016;11:454–459. doi:10.4103/1673-5374.179058
   PubMed Web of Science ®Google Scholar
• Corson T, Crews C. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell. 2007;130(5):769–774. doi:10.1016/j.cell.2007.08.021
   PubMed Web of Science ®Google Scholar
• Guo L, Luo S, Du Z, et al. Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis. Nat Commun. 2017;8(1):878. doi:10.1038/s41467-017-00834-8
   PubMed Web of Science ®Google Scholar
• Kang S, Park T, Chen X, et al. Tunable physiologic interactions of adhesion molecules for inflamed cell-selective drug delivery. Biomaterials. 2011;32(13):3487–3498. doi:10.1016/j.biomaterials.2011.01.046
   PubMed Web of Science ®Google Scholar
• Li X, Xie S, Pan Y, et al. Preparation, characterization and pharmacokinetics of doxycycline hydrochloride and florfenicol polyvinylpyrroliddone microparticle entrapped with hydroxypropyl-β-cyclodextrin inclusion complexes suspension. Colloids Surf B. 2016:634–642. doi:10.1016/j.colsurfb.2016.02.027
   PubMed Web of Science ®Google Scholar
• Gao L, Chen Y, Zhang N, et al. Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med. 2015. doi:10.1186/s12916-015-0399-z
   Web of Science ®Google Scholar
• Chen J, Gong Y, Liu J, et al. Synthesis and biological evaluation of substituted phenylpyrazole oleanane derivatives as inhibitors of glycogen phosphorylase. Drug Discoveries Ther. 2008;2(2):115–121. doi:10.1002/cbdv.200890117
   PubMedGoogle Scholar
• Qu D, He J, Liu C, et al. Triterpene-loaded microemulsion using Coix lacryma-jobi seed extract as oil phase for enhanced antitumor efficacy: preparation and in vivo evaluation. Int j Nanomed. 2014;9(1):109–119. doi:10.2147/IJN.S54796
   PubMedGoogle Scholar
• Chen Y, Qu D, Fu R, et al. A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment. Int j Nanomed. 2018;13:7275–7287. doi:10.2147/IJN.S182475
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo M, Qu D, et al. Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation. Drug Delivery. 2020;27(1):1608–1624. doi:10.1080/10717544.2020.1827086
   PubMed Web of Science ®Google Scholar
• Chen Y, Yuan L, Congyan L, et al. Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model. Int j Nanomed. 2013;8. doi:10.2147/IJN.S51621
   Web of Science ®Google Scholar
• Qu D, Wang L, Liu M, et al. Oral nanomedicine based on multicomponent microemulsions for drug-resistant breast cancer treatment. Biomacromolecules. 2017;18(4):1268–1280. doi:10.1021/acs.biomac.7b00011
   PubMed Web of Science ®Google Scholar
• Ding Q, Mingjian L, Mengmeng H, et al. Octanoyl galactose ester-modified microemulsion system self-assembled by coix seed components to enhance tumor targeting and hepatoma therapy. Int j Nanomed. 2017;12:2045–2059. doi:10.2147/IJN.S125293
   PubMed Web of Science ®Google Scholar
• Qu D, Wang L, Qin Y, et al. Non-triggered sequential-release liposomes enhance anti-breast cancer efficacy of STS and celastrol-based microemulsion. Biomater. Sci. 2018;6(12):3284–3299. doi:10.1039/c8bm00796a
   PubMed Web of Science ®Google Scholar
• Li P, Zhou X, Qu D, et al. Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2. Drug Deliv. 2017;24(1):834–845. doi:10.1080/10717544.2017.1326540
   PubMed Web of Science ®Google Scholar
• Wong S, Kellaway I, Murdan S. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int J Pharm. 2006;317(1):61–68. doi:10.1016/j.ijpharm.2006.03.001
   PubMedGoogle Scholar
• Guang H, Zhao Q, Du B, et al. Platelet-rich plasma protects human keratinocytes from UVB-induced apoptosis by attenuating inflammatory responses and endoplasmic reticulum stress. J Cosmet Dermatol. 2023;22(4):1327–1333. doi:10.1111/jocd.15559
   PubMed Web of Science ®Google Scholar
• Ceylan S. An in vitro evaluation of Genipin-crosslinked and Hypericum perforatum incorporated novel membranes for skin tissue engineering applications. J Appl Polym Sci. 2021;138. doi:10.1002/app.51385
   Web of Science ®Google Scholar
• Poley M, Chen G, Sharf-Pauker N, et al. Sex-based differences in the biodistribution of nanoparticles and their effect on hormonal, immune, and metabolic function. Adv Nano Biomed Res. 2022;2(12). doi:10.1002/anbr.202200089
   Google Scholar
• Haney M, Yuan H, Shipley S, et al. Biodistribution of biomimetic drug carriers, mononuclear cells, and extracellular vesicles, in nonhuman primates. Adv Biol. 2021;6(2):e2101293. doi:10.1002/adbi.202101293
   Google Scholar
• Song G, Tarrant T, White T, et al. Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer. Nanomed Nanotechnol Biol Med. 2015;11(7):1797–1807. doi:10.1016/j.nano.2015.05.007
   PubMed Web of Science ®Google Scholar
• Gonzalezvillasana V, Rodriguezaguayo C, Arumugam T, et al. Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2014;13(11):2583. doi:10.1158/1535-7163.MCT-14-0028
   PubMed Web of Science ®Google Scholar
• Kim S, Noh Y, Kang T, et al. Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity. Biomaterials. 2017;130:56–66. doi:10.1016/j.biomaterials.2017.03.034
   PubMed Web of Science ®Google Scholar
• Lau U, Saxer S, Lee J, et al. Direct write protein patterns for multiplexed cytokine detection from live cells using electron beam lithography. Acs Nano. 2016;10(1):723–729. doi:10.1021/acsnano.5b05781
   PubMed Web of Science ®Google Scholar
• Koonce N, Quick C, Hardee M, et al. Combination of gold nanoparticle-conjugated tumor necrosis factor-α and radiation therapy results in a synergistic antitumor response in murine carcinoma models. Int J Radiat Oncol Biol Phys. 2015;93(3):588–596. doi:10.1016/j.ijrobp.2015.07.2275
   PubMed Web of Science ®Google Scholar
• Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45–65. doi:10.1038/sj.cdd.4401189
   PubMed Web of Science ®Google Scholar
• Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin. 2010;29(11):1275–1288. doi:10.1111/j.1745-7254.2008.00889.x
   Web of Science ®Google Scholar
• Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13(2):135–141. doi:10.1016/s1359-6101(01)00020-x
   PubMed Web of Science ®Google Scholar
• Esther S, Tsipi M, Polina W, et al. Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer. 2011;11(1):130. doi:10.1186/1471-2407-11-130
   PubMedGoogle Scholar
• Komohara Y, Fujiwara Y, Ohnishi K, et al. Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. Adv. Drug Delivery Rev. 2016;99(Pt B):180–185. doi:10.1016/j.addr.2015.11.009
   PubMedGoogle Scholar
• Bunimovich-Mendrazitsky S, Halachmi S, Kronik N. ImprovingBacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model. Math Med Biol. 2016;33(2):159–188. doi:10.1093/imammb/dqv007
   PubMed Web of Science ®Google Scholar
• Wu J, Cui T, Yin C. Co-delivery of doxorubicin and interleukin-2 via chitosan-based nanoparticles for enhanced antitumor efficacy. Acta Biomater. 2017;47:81–90. doi:10.1016/j.actbio.2016.10.012
   PubMed Web of Science ®Google Scholar
• Kong H, Zhuo C, Yi K, et al. Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection. Nano Today. 2023:53. doi:10.1016/j.nantod.2023.102040
   Web of Science ®Google Scholar
• Kong H, Ju E, Yi K, et al. Advanced nanotheranostics of CRISPR/Cas for viral hepatitis and hepatocellular carcinoma. Adv Sci. 2021;8. doi:10.1002/advs.202170163
   Web of Science ®Google Scholar